Apollo Endosurgery (APEN) Misses Q2 EPS by 9c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. SPCX
2. SBUX
3. LEVI
4. NVDA
5. GOOGL
6. ORCL
7. USO
8. STZ
9. AAPL
10. SPY

Go back to Apollo Endosurgery (APEN) Misses Q2 EPS by 9c

Apollo Endosurgery, Inc. Reports Second Quarter 2018 Results

August 8, 2018 4:01 PM EDT

OverStitch Product Sales Increase 37% Year-Over-Year

Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET

AUSTIN, Texas--(BUSINESS WIRE)-- Apollo Endosurgery, Inc. ("Apollo") (Nasdaq: APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced financial results for the second quarter ended June 30, 2018.

Second Quarter 2018 Highlights

OverStitch became Apollo's top selling product in U.S. and OUS direct markets Completed public offering of common stock generating net proceeds of $21.9 million... More